We are live on ! Find out more
NRXS icon

Neuraxis
NRXS

7 hedge funds and large institutions have $201K invested in Neuraxis in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

17% more funds holding

Funds holding: 6 → 7 (+1)

0.33% more ownership

Funds ownership: 1.09% → 1.43% (+0.33%)

3% less capital invested

Capital invested by funds: $207K → $201K (-$5.82K)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$48.1K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$38.2K
3
PCM
Parsons Capital Management
Rhode Island
+$35.2K
4
TRCT
Tower Research Capital (TRC)
New York
+$10.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$5

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$98.8K
2
UBS Group
UBS Group
Switzerland
-$6.46K

NRXS Hedge Fund Activity: Q4 2023 in Review

7 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q4 2023, worth a combined $201K — down 2.8% from $207K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NRXS positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $48.1K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $98.8K sold.

  • 7 institutional investors held Neuraxis (NRXS) as of Q4 2023, up from 6 in Q3 2023.
  • Funds reported $201K of Neuraxis stock for Q4 2023, down 2.8% quarter-over-quarter.
  • 3 funds opened new Neuraxis positions in Q4 2023 and 2 closed out, a net change of +1 holder.
  • The largest Neuraxis buyer in Q4 2023 was Vanguard Group, an estimated $48.1K added.
  • The largest Neuraxis seller in Q4 2023 was Bank of New York Mellon, an estimated $98.8K sold.

Based on aggregated 13F filings for Q4 2023.